What happens metabolically after injections are discontinued?
Hormone-mimicking medicines adjust appetite and insulin dynamics; the body readapts when they are withdrawn.
Appetite-regulating pathways gradually normalise; hunger cues may increase. Glycaemic markers can shift in patients with diabetes—monitoring is essential.
Without continued calorie awareness, fat regain can exceed lean mass restoration, worsening metabolic risk. Structured follow-up improves odds of stability.
Some patients rotate between pharmacologic and procedural strategies over years as guidelines and personal situations evolve.
Individual prediction is imperfect; shared decision-making with a metabolic specialist is key.
This content is for general education only and does not replace an individual medical consultation.